Jeil Pharmaceutical completes Baekam expansion, lifting oral drug capacity 71%
AI Summary- Jeil Pharmaceutical completed and received approval for the Baekam plant expansion in Yongin.
- The 24.9 billion-won project is expected to increase oral drug capacity by about 71%.
- Jaqubo generated 64.5 billion won in first-half revenue, up roughly 152% year over year.